Application of gene therapy to treat age-related loss of dopamine D2 receptor
- PMID: 9951623
- DOI: 10.1016/s0531-5565(98)00043-6
Application of gene therapy to treat age-related loss of dopamine D2 receptor
Abstract
We have investigated the feasibility of using gene therapy to attenuate the age-related decline in striatal dopamine D2 receptors (D2R) associated with reduced motor control. To this end, we have constructed an adenoviral vector containing the cDNA for the rat D2R. When injected into HeLa and HS24 cells in vitro, the vector induced an abundant message for D2R, as demonstrated by Northern analysis, and produced a membrane-bound protein capable of binding a D2R ligand, [3H]spiperone. When injected into rat striatum in vivo, the vector produced a marked increase in D2R near the site of injection, as evidenced by increased [3H]spiperone binding as well as by another more specific ligand, [125I]iodosulpride. The D2R produced in the striatum were functional, as evidenced by rotational behavior induced by a subcutaneous injection of the dopamine agonist, apomorphine. However, we did not observe any significant improvement in motor performance during preliminary experiments in which aged rats received bilateral striatal injections of the vector. In young rats, vector-induced expression of D2R in striatum was increased markedly three to five days after infection, but then declined to baseline levels by day 21. Loss of expression in aged rats proceeded at a somewhat lower rate. Because of the loss of expression and lack of significant performance enhancement in aged rats following vector injection into the striatum, we are now pursuing other strategies. These include functional assessment of the current vector in D2R null mutant mice as well as construction of new vectors that may yield more long-term expression.
Similar articles
-
Development of an adenoviral vector for intracerebral delivery of the dopamine D(2) receptor.Mech Ageing Dev. 2000 Jul 31;116(2-3):77-93. doi: 10.1016/s0047-6374(00)00113-5. Mech Ageing Dev. 2000. PMID: 10996008 Review.
-
[Gene therapy to treat Parkinson's disease].Nihon Ronen Igakkai Zasshi. 1999 Feb;36(2):103-9. doi: 10.3143/geriatrics.36.103. Nihon Ronen Igakkai Zasshi. 1999. PMID: 10363527 Japanese.
-
Rotational behavior produced by adenovirus-mediated gene transfer of dopamine D2 receptor into rat striatum.Neuroreport. 1997 Nov 10;8(16):3553-8. doi: 10.1097/00001756-199711100-00027. Neuroreport. 1997. PMID: 9427325
-
Longitudinal follow-up study of adenoviral vector-mediated gene transfer of dopamine D2 receptors in the striatum in young, middle-aged, and aged rats: a positron emission tomography study.Neuroscience. 2003;121(2):479-86. doi: 10.1016/s0306-4522(03)00489-5. Neuroscience. 2003. PMID: 14522006
-
Adenovirus-mediated gene transfer of dopamine D2 receptor cDNA into rat striatum.Brain Res Mol Brain Res. 1995 Dec 28;34(2):315-20. doi: 10.1016/0169-328x(95)00185-u. Brain Res Mol Brain Res. 1995. PMID: 8750835
Cited by
-
Age-associated improvements in cross-modal prepulse inhibition in mice.Behav Neurosci. 2010 Feb;124(1):133-140. doi: 10.1037/a0018462. Behav Neurosci. 2010. PMID: 20141288 Free PMC article.
-
Do Dopaminergic Impairments Underlie Physical Inactivity in People with Obesity?Front Hum Neurosci. 2016 Oct 14;10:514. doi: 10.3389/fnhum.2016.00514. eCollection 2016. Front Hum Neurosci. 2016. PMID: 27790107 Free PMC article. Review.
-
Aging of the striatum: mechanisms and interventions.Age (Dordr). 2008 Dec;30(4):251-61. doi: 10.1007/s11357-008-9066-z. Epub 2008 Jul 3. Age (Dordr). 2008. PMID: 19424849 Free PMC article.
-
D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats.Synapse. 2008 Jul;62(7):481-6. doi: 10.1002/syn.20523. Synapse. 2008. PMID: 18418874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical